CBS9106 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a selective inhibitor of certain enzymes that are involved in the regulation of cell cycle and growth. By inhibiting these enzymes, CBS9106 can potentially halt the proliferation of cancer cells, making it a subject of interest in the development of targeted cancer treatments. Researchers are exploring its efficacy and safety in preclinical studies to determine its potential as a therapeutic agent in oncology.